Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.

Roff SR, Noon-Song EN, Yamamoto JK.

Front Immunol. 2014 Jan 13;4:498. doi: 10.3389/fimmu.2013.00498. eCollection 2014 Jan 13. Review.

PMID:
24454311
[PubMed]
Free PMC Article
2.

Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.

Vargas-Inchaustegui DA, Xiao P, Hogg AE, Demberg T, McKinnon K, Venzon D, Brocca-Cofano E, Dipasquale J, Lee EM, Hudacik L, Pal R, Sui Y, Berzofsky JA, Liu L, Langermann S, Robert-Guroff M.

Virology. 2013 Dec;447(1-2):274-84. doi: 10.1016/j.virol.2013.09.015. Epub 2013 Oct 9.

PMID:
24210124
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it?

McIlroy D.

Front Immunol. 2013 Mar 1;4:52. doi: 10.3389/fimmu.2013.00052. eCollection 2013.

PMID:
23459829
[PubMed]
Free PMC Article
4.

HIV-specific CD8+ T cells from elite controllers are primed for survival.

Yan J, Sabbaj S, Bansal A, Amatya N, Shacka JJ, Goepfert PA, Heath SL.

J Virol. 2013 May;87(9):5170-81. doi: 10.1128/JVI.02379-12. Epub 2013 Feb 28.

PMID:
23449791
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.

Paley MA, Kroy DC, Odorizzi PM, Johnnidis JB, Dolfi DV, Barnett BE, Bikoff EK, Robertson EJ, Lauer GM, Reiner SL, Wherry EJ.

Science. 2012 Nov 30;338(6111):1220-5. doi: 10.1126/science.1229620.

PMID:
23197535
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.

Perez-Mazliah DE, Alvarez MG, Cooley G, Lococo BE, Bertocchi G, Petti M, Albareda MC, Armenti AH, Tarleton RL, Laucella SA, Viotti R.

J Antimicrob Chemother. 2013 Feb;68(2):424-37. doi: 10.1093/jac/dks390. Epub 2012 Oct 26.

PMID:
23104493
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency.

Pace MJ, Graf EH, Agosto LM, Mexas AM, Male F, Brady T, Bushman FD, O'Doherty U.

PLoS Pathog. 2012;8(7):e1002818. doi: 10.1371/journal.ppat.1002818. Epub 2012 Jul 26.

PMID:
22911005
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Disease Progression in HIV-1-Infected Viremic Controllers.

Groves KC, Bibby DF, Clark DA, Isaksen A, Deayton JR, Anderson J, Orkin C, Stagg AJ, McKnight A.

J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):407-16. doi: 10.1097/QAI.0b013e318269c414.

PMID:
22902723
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Characterization of peripheral and mucosal immune responses in rhesus macaques on long-term tenofovir and emtricitabine combination antiretroviral therapy.

Jasny E, Geer S, Frank I, Vagenas P, Aravantinou M, Salazar AM, Lifson JD, Piatak M Jr, Gettie A, Blanchard JL, Robbiani M.

J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):425-35. doi: 10.1097/QAI.0b013e318266be53.

PMID:
22820802
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.

Lisziewicz J, Bakare N, Calarota SA, Bánhegyi D, Szlávik J, Ujhelyi E, Tőke ER, Molnár L, Lisziewicz Z, Autran B, Lori F.

PLoS One. 2012;7(5):e35416. doi: 10.1371/journal.pone.0035416. Epub 2012 May 9.

PMID:
22590502
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants.

Holditch SJ, Eriksson EM, Tarosso LF, Kuebler PJ, Kallas EG, Nielsen EK, Wiznia AA, Rosenberg MG, Nixon DF.

Front Immunol. 2012 Jan 11;2:94. doi: 10.3389/fimmu.2011.00094. eCollection 2011.

PMID:
22566883
[PubMed]
Free PMC Article
12.

In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.

Kitchen SG, Levin BR, Bristol G, Rezek V, Kim S, Aguilera-Sandoval C, Balamurugan A, Yang OO, Zack JA.

PLoS Pathog. 2012;8(4):e1002649. doi: 10.1371/journal.ppat.1002649. Epub 2012 Apr 12.

PMID:
22511873
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.

Conrad JA, Ramalingam RK, Duncan CB, Smith RM, Wei J, Barnett L, Simons BC, Lorey SL, Kalams SA.

J Virol. 2012 Apr;86(8):4213-21. doi: 10.1128/JVI.06000-11. Epub 2012 Jan 18.

PMID:
22258246
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation.

Janbazian L, Price DA, Canderan G, Filali-Mouhim A, Asher TE, Ambrozak DR, Scheinberg P, Boulassel MR, Routy JP, Koup RA, Douek DC, Sekaly RP, Trautmann L.

J Immunol. 2012 Feb 1;188(3):1156-67. doi: 10.4049/jimmunol.1102610. Epub 2011 Dec 30.

PMID:
22210916
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Berger CT, Frahm N, Price DA, Mothe B, Ghebremichael M, Hartman KL, Henry LM, Brenchley JM, Ruff LE, Venturi V, Pereyra F, Sidney J, Sette A, Douek DC, Walker BD, Kaufmann DE, Brander C.

J Virol. 2011 Sep;85(18):9334-45. doi: 10.1128/JVI.00460-11. Epub 2011 Jul 13.

PMID:
21752903
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.

Keane NM, Roberts SG, Almeida CA, Krishnan T, Chopra A, Demaine E, Laird R, Tschochner M, Carlson JM, Mallal S, Heckerman D, James I, John M.

Immunol Cell Biol. 2012 Feb;90(2):224-34. doi: 10.1038/icb.2011.34. Epub 2011 May 17.

PMID:
21577229
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.

Serwanga J, Mugaba S, Betty A, Pimego E, Walker S, Munderi P, Gilks C, Gotch F, Grosskurth H, Kaleebu P.

AIDS Res Treat. 2011;2011:875028. doi: 10.1155/2011/875028. Epub 2011 Jan 18.

PMID:
21490785
[PubMed]
Free PMC Article
18.

Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors.

Cellerai C, Harari A, Stauss H, Yerly S, Geretti AM, Carroll A, Yee T, Ainsworth J, Williams I, Sweeney J, Freedman A, Johnson M, Pantaleo G, Kinloch-de Loes S.

PLoS One. 2011 Apr 5;6(4):e18164. doi: 10.1371/journal.pone.0018164.

PMID:
21483676
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.

Chapuis AG, Casper C, Kuntz S, Zhu J, Tjernlund A, Diem K, Turtle CJ, Cigal ML, Velez R, Riddell S, Corey L, Greenberg PD.

Blood. 2011 May 19;117(20):5391-402. doi: 10.1182/blood-2010-11-320226. Epub 2011 Mar 21.

PMID:
21422474
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The role of recombination for the coevolutionary dynamics of HIV and the immune response.

Mostowy R, Kouyos RD, Fouchet D, Bonhoeffer S.

PLoS One. 2011 Feb 18;6(2):e16052. doi: 10.1371/journal.pone.0016052.

PMID:
21364750
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk